1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Cardiol Therapeutics Inc.US flagNASDAQ Capital Market
1.73
USD
-0.04
- -
199.42MMarket Cap

Total Valuation

Cardiol Therapeutics Inc. carries a market capitalization of 199.42M, placing it among publicly traded companies globally. Its enterprise value stands at 147.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap199.42M
Enterprise Value147.46M

Share Statistics

Cardiol Therapeutics Inc. currently has 115.27M shares outstanding.

Shares Outstanding115.27M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio7.22
P/TBV Ratio7.22
P/FCF Ratio-6.45
P/OCF Ratio-6.44

Financial Position

Cardiol Therapeutics Inc. maintains a current ratio of 5.55, meaning it holds 5.5x the short-term assets needed to cover near-term liabilities.

Current Ratio5.55
Quick Ratio5.01
Debt / Equity0.45
Debt / EBITDA0.00
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)-190.18
Return on Assets (ROA)-138.26
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Cardiol Therapeutics Inc.'s stock has gained approximately 60.18519% over the past 52 weeks. The 50-day moving average sits at 1.68, while the 200-day moving average is 1.26.

Beta (5Y)N/A
52-Week Price Change60.18519%
50-Day Moving Average1.68
200-Day Moving Average1.26
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -35.77M, while operating income came in at -35.86M.

RevenueN/A
Gross ProfitN/A
Operating Income-35.86M
Pretax Income-34.08M
Net Income-34.08M
EBITDA-35.77M
EBIT-35.86M
Earnings Per Share (EPS)-0.33

Balance Sheet

Cardiol Therapeutics Inc. holds 26.08M in cash and equivalents against 106,998.00 in total debt, resulting in a net debt position of -26.08M. Total book value stands at 24.03M, with working capital of 23.96M providing operational flexibility.

Cash & Cash Equivalents26.08M
Total Debt106,998.00
Net Debt-26.08M
Equity (Book Value)24.03M
Book Value Per Share0.21
Working Capital23.96M

Cash Flow

Cardiol Therapeutics Inc. produced -24.05M in operating cash flow over the past twelve months. After subtracting -56,720.00 in capital expenditures, free cash flow totaled -24.10M - equivalent to -0.23 per share.

Operating Cash Flow-24.05M
Capital Expenditures-56,720.00
Free Cash Flow-24.10M
FCF Per Share-0.23

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-18.23
FCF Yield-15.50

Scores

Cardiol Therapeutics Inc. posts an Altman Z-Score of 5.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.51